AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)
AUAUniversity30 Heinä 2025

AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)

AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs) CME Available: https://auau.auanet.org/node/43009 At the conclusion of this activity, participants will be able to: 1. Identify the guidelines for first-line and beyond treatment of patients with hormone-sensitive advanced and metastatic prostate cancer, including medications, their mechanism, side effects and efficacy. 2. Summarize the recommendations for first-line and beyond treatment of castrate-resistant metastatic and nonmetastatic prostate cancer, including medications, their mechanism, side effects and efficacy. 3. Diagram the treatment options for high-risk non-muscle invasive bladder cancer. 4. Distinguish the guideline-defined therapeutic options for locally advanced and metastatic bladder cancer. 5. Discuss treatment options for locally advanced and metastatic kidney cancer, including medications, their mechanism, side effects and efficacy. ACKNOWLEDGEMENTS: This educational activity is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Novartis Pharmaceuticals Corporation, Pfizer, Inc.

Jaksot(421)

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

The goal of the course is to provide both a basic and real-world application of immunotherapy for genitourinary oncology. The course is directed towards the urologist with an interest, but no prior ex...

1 Elo 20181h 55min

AUA2018 063IC - Prostate Cancer Update

AUA2018 063IC - Prostate Cancer Update

This course will offer a review of what faculty believe are the most important articles in the English-speaking literature on prostate cancer from May 2017 to April 2018. Focus will be placed on artic...

29 Heinä 20181h 59min

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, and prostate cancers. Indications, outcomes, and toxicities will be discussed as wel...

25 Heinä 20181h 54min

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether bi...

11 Heinä 20182h 1min

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

5 Heinä 201831min

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active...

23 Kesä 20182h 12min

Focal Therapy Interview with John W. Davis, MD, FACS

Focal Therapy Interview with John W. Davis, MD, FACS

Dr. Nitti and Dr. Davis discus the use of focal therapy in the treatment of prostate cancer. @jdhdavis - This file has been updated

15 Kesä 201833min

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

8 Kesä 201842min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
rss-duodecim-lehti
jari-sarasvuo-podcast
leveli
rss-liian-kuuma-peruna
rss-valo-minussa-2
rss-koira-haudattuna
rahapuhetta
rss-niinku-asia-on
salainen-paivakirja
psykologia
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-uskonto-on-tylsaa
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
rss-arkea-ja-aurinkoa-podcast-espanjasta